The United States: DHZC-2 Tablet by Ton Shen Health: Recall - Possible Health Risk (English Only)

 

The United States: DHZC-2 Tablet by Ton Shen Health: Recall - Possible Health Risk (English Only)
 
The Food and Drug Administration (FDA) announced that Ton Shen Health of Chicago, IL, is recalling its “DHZC-2” Tablets because they have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and particularly harmful to young children. Lead poisoning can happen if a person is exposed to high levels of lead over short period of time. One illness has been reported to date in connection with this problem. 

The recalled "DHZC-2" tablets were mostly sold locally in Chicago area in retails stores and some were distributed to other states through mail orders. The product comes in a 1.6 ounce, white plastic package marked with lot # 2163-844 on the bottom. UPC: 616042102727. The potential for contamination was noted after FDA notice of higher level of lead presence in DHZC-2 samples. The sale of the product has been suspended and inventory put on hold while FDA and the company continue to investigate the source of the problem. 

Please refer to the following website in FDA for details:http://www.fda.gov/Safety/MedWatch/../ucm516496.htm 

In Hong Kong, the above product is not a registered pharmaceutical product and no registered pharmaceutical product is manufactured or held by Ton Shen Health. 

Ends/ Saturday, August 13, 2016 
Issued at HKT 13:00 
 
The United States: DHZC-2 Tablet by Ton Shen Health: Recall - Possible Health Risk (English Only)
 
The Food and Drug Administration (FDA) announced that Ton Shen Health of Chicago, IL, is recalling its “DHZC-2” Tablets because they have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and particularly harmful to young children. Lead poisoning can happen if a person is exposed to high levels of lead over short period of time. One illness has been reported to date in connection with this problem. 

The recalled "DHZC-2" tablets were mostly sold locally in Chicago area in retails stores and some were distributed to other states through mail orders. The product comes in a 1.6 ounce, white plastic package marked with lot # 2163-844 on the bottom. UPC: 616042102727. The potential for contamination was noted after FDA notice of higher level of lead presence in DHZC-2 samples. The sale of the product has been suspended and inventory put on hold while FDA and the company continue to investigate the source of the problem. 

Please refer to the following website in FDA for details:http://www.fda.gov/Safety/MedWatch/../ucm516496.htm 

In Hong Kong, the above product is not a registered pharmaceutical product and no registered pharmaceutical product is manufactured or held by Ton Shen Health. 

Ends/ Saturday, August 13, 2016 
Issued at HKT 13:00 
 

 

轉載香港特別行政區轄下衛生署最新消息